Interleukins Profiling in Umbilical Cord Mesenchymal Stem Cell-Derived Secretome
Angliana Chouw,Cynthia Retna Sartika,Tiana Milanda,Ahmad Faried
DOI: https://doi.org/10.2147/SCCAA.S356763
2022-04-15
Stem Cells and Cloning: Advances and Applications
Abstract:Angliana Chouw, 1, 2 Cynthia Retna Sartika, 2 Tiana Milanda, 3 Ahmad Faried 4 1 Doctoral Program, Faculty of Pharmacy Universitas Padjadjaran, Jatinangor, West Java, Indonesia; 2 Research and Development, Prodia StemCell Indonesia, Jakarta, DKI, Jakarta, Indonesia; 3 Department of Biological Pharmacy, Faculty of Pharmacy Universitas Padjadjaran, Jatinangor, West Java, Indonesia; 4 Stem Cell Working Group, Faculty of Medicine Universitas Padjadjaran, Dr. Hasan Sadikin Hospital, Bandung, West Java, Indonesia Correspondence: Angliana Chouw; Tiana Milanda, Email ; Background: Umbilical cord mesenchymal stem cells (UC-MSCs)-derived secretome is currently used in regenerative therapy. MSCs are believed to secrete a wide spectrum of bioactive molecules which give paracrine effects in immunomodulation and regenerative capacities. One group that was found in secretome is interleukins (ILs), a cytokine that plays an essential role in the process of proliferation, differentiation, maturation, migration, and adhesion of immune cells. However, as there are many types of ILs, the profile of ILs in the UC-MSCs-derived secretome has been limitedly reported. Therefore, in this study, we would like to profile and detect the interleukin concentration secreted by UC-MSCs. Methods: UC-MSCs-derived secretome was collected from UC-MSCs passage 5 after 24- and 48-hour incubation (n=9). Secretome was filtered using 0.2 μm and stored at − 80°C for further detection. All samples were normalized before the interleukin (IL-2, IL-4, IL-6, IL-9, IL-10, IL-12, IL-17A) detection using a MACSPlex Cytokine Kit. Results: The IL-6 has the highest concentration among other interleukins in both groups and increases significantly ( p < 0.003) after incubation for 48 hours. The pro-inflammatory factors are decreasing while anti-inflammatory factors are increasing after 48-hour incubation. Discussion: Our studies show that the UC-MSCs secrete pro- and anti-inflammatory interleukins. The concentration of anti-inflammatory interleukins shows to be increasing, while the pro-inflammatory interleukins are decreasing within the longer incubation time, but this not be applicable for IL-10 and IL-6. IL-6 has the highest concentration among other ILs. These results may provide important clues regarding when is the right time for secretome to be used in therapy patients, because all the molecules in the secretome can lead to many clinical manifestations. Keywords: secretome, mesenchymal stem cell, interleukin, conditioned medium, umbilical cord In recent years, mesenchymal stem cells (MSCs) have gained much interest as therapeutic agents for immunomodulation and tissue regeneration in regenerative medicine. 1 The MSCs are shown to have the ability to differentiate into various cell. 2 While most of the sources of MSCs show the same characteristics as the minimal criteria release by the International Society of Cell and Gene Therapy (ISCT), the umbilical cord (UC) tissue is reported to be an eminent source of human MSCs (hMSCs) compared to other sources. 3,4 The UC-MSCs are reported to have more immune privilege than the other sources because they show less immunogenicity, and also have a higher proliferation capacity. Besides that, when UC tissues are collected as the source of MSCs, the process is proved to be less invasive compared to the process of adipose tissue and bone marrow collection. 5,6 Although there are limited reports that the transplanted MSCs in humans lead to graft rejection, the cell-free therapy using MSCs-derived secretome is currently in great demand for clinical application. 7 The paracrine effects hypothesis becomes more consolidated because the MSCs secrete a wide spectrum of bioactive molecules that contains extracellular vesicles, proteins, growth factors, lipids, chemokines, and cytokines. 8 These bioactive molecules are referred to as secretome, which holds capacity as immunomodulatory and regenerative agents to repair and maintain the homeostasis in injured tissues. 9 The therapeutic effects of secretome rely on the factors inside the secretome. Many physiological processes such as cells apoptosis, proliferation, migration, and angiogenesis are regulated by the extracellular vesicles in the secretome. 9 However, some difficulties arise in obtaining MSCs-derived secretome due to the complex mechanisms of the production process. Many factors could affect the secretion of MSCs' secretome, such as the source of MSCs, the culturing method, the pre-conditioning treatment during in vitro culture, and others. 10–12 Hence, there are many studies which have tried to -Abstract Truncated-